Journal of Clinical & Experimental Pathology
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Lymphocytes play key roles in the chronic inflammation critical for T2D pathogenesis. We have shown T2D patients have
an elevated ratio of pro- to anti-inflammatory T cells, and B cells that produce a pro-inflammatory cytokine profile. Thus
lymphocytes promote T2D-associated inflammation. Although the pro-inflammatory CD4
T cell balance has been specifically
implicated in T2D pathogenesis by numerous studies, mechanisms that underlie elevated CD4+ T cell inflammation are poorly
understood. B cells have recently become appreciated as regulators of CD4+ T cell subset differentiation and function, but the
possibility that the T2D-associated changes we identified in B cell function regulate T cell inflammation in T2D is untested.
Our new data demonstrate that B cells control the T2D-associated increase in CD4+ Th17-mediated inflammation in both T2D
patients and in obese/insulin resistant mice. Surprisingly, the disease-associated ability of B cells to regulate T cell function was
contact-dependent, despite the demonstration that multiple cytokines hyper-secreted by B cells from T2D patients activate T
cells. In contrast, elevated activation of CD4+ Th1 axis cytokines was B cell-independent. We conclude that both T cell-intrinsic
and T cell-extrinsic changes regulate T cell-mediated inflammation in T2D. These data indicate that B cell depletion may partially
curb T2D-associated T cell inflammation thus disease pathogenesis, but that combinatorial treatments may be required for
favorable clinical outcomes. Thus our work suggests that the currently modest efficacy of anti-inflammatory drugs in T2D may
be predictable, and that drug combinations will be required to leverage our understanding of T2D as an inflammatory disease
into new treatments.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals